Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-30Effect of PDE5 Inhibition on Adipose Metabolism in Humans
-
CLINICAL_TRIALS study record update · 2026-07-30A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-07-30A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease
-
CLINICAL_TRIALS study results posted · 2026-07-27Time Restricted Eating for Weight Management
-
CLINICAL_TRIALS study record update · 2026-07-27A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HRS-7535 Tablets in Subjects With Overweight or Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-07-23A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study results posted · 2026-07-22A Pilot Randomized Clinical Trial of Walking, Dance, and Abdominal Core Workouts to Improve Adipocytokines Among Insufficiently Active Adults With Obesity
-
CLINICAL_TRIALS study results posted · 2026-07-20A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Japanese Adult Participants With Obesity Disease
-
CLINICAL_TRIALS study results posted · 2026-07-17Assessing the Effect of Diet on Hypothalamic Gliosis in Humans
-
CLINICAL_TRIALS study results posted · 2026-07-17A Multiple Dose Titration Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3502970 in Chinese Participants Who Have Obesity or Are Overweight With Weight-related Comorbidities
-
CLINICAL_TRIALS study results posted · 2026-07-17A Multiple-Dose Study to Investigate the Bioequivalence of Orforglipron (LY3502970) Capsules and Orforglipron Tablets in Participants With Obesity or Overweight Who Are Otherwise Healthy.
-
CLINICAL_TRIALS study record update · 2026-07-09A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study results posted · 2026-07-02Impact of Dietary Fiber as Prebiotics on Intestinal Microbiota in Obese Thai Children
-
CLINICAL_TRIALS study results posted · 2026-07-02Laparoscopic TAP Block for Sleeve Gastrectomy: Does Timing Matter
-
CLINICAL_TRIALS study record update · 2026-06-29A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study results posted · 2026-06-24A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-06-24A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study results posted · 2026-06-17Continuous Glucose Monitors in the Management of Youth With Prediabetes
-
CLINICAL_TRIALS study record update · 2026-06-17Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)
-
CLINICAL_TRIALS study record update · 2026-06-11A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD
-
CLINICAL_TRIALS study record update · 2026-06-09A Phase 3b Study to Investigate the Efficacy and Safety of Different Retatrutide Dose Escalation Schemes in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Controlled, Double-Blind Trial
-
CLINICAL_TRIALS study record update · 2026-06-08Lifestyle Interventions for Expectant Moms (LIFE-Moms) Phoenix
-
CLINICAL_TRIALS study record update · 2026-06-08A Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects
-
CLINICAL_TRIALS study record update · 2026-06-04A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Orforglipron Once Daily Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
-
CLINICAL_TRIALS study record update · 2026-06-03A Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects